BNP Paribas Financial Markets’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $29.7M | Buy |
94,072
+59,157
| +169% | +$13.9M | 0.01% | 1032 |
|
|
2026
Q1 | $6.97M | Sell |
34,915
-42
| -0.1% | -$8.31K | ﹤0.01% | 1785 |
|
|
2025
Q4 | $6.61M | Buy |
34,957
+30,865
| +754% | +$5.93M | ﹤0.01% | 1859 |
|
|
2025
Q3 | $725K | Buy |
4,092
+1,996
| +95% | +$297K | ﹤0.01% | 3356 |
|
|
2025
Q2 | $238K | Buy |
2,096
+680
| +48% | +$72.7K | ﹤0.01% | 3711 |
|
|
2025
Q1 | $149K | Sell |
1,416
-1,012
| -42% | -$114K | ﹤0.01% | 3873 |
|
|
2024
Q4 | $260K | Sell |
2,428
-1,728
| -42% | -$195K | ﹤0.01% | 3716 |
|
|
2024
Q3 | $416K | Sell |
4,156
-1,586
| -28% | -$160K | ﹤0.01% | 2936 |
|
|
2024
Q2 | $484K | Sell |
5,742
-3,554
| -38% | -$283K | ﹤0.01% | 2684 |
|
|
2024
Q1 | $680K | Sell |
9,296
-9,186
| -50% | -$677K | ﹤0.01% | 2684 |
|
|
2023
Q4 | $1.32M | Sell |
18,482
-2,299
| -11% | -$136K | ﹤0.01% | 2221 |
|
|
2023
Q3 | $1.25M | Buy |
20,781
+15,069
| +264% | +$992K | ﹤0.01% | 2192 |
|
|
2023
Q2 | $412K | Sell |
5,712
-5,123
| -47% | -$384K | ﹤0.01% | 2684 |
|
|
2023
Q1 | $797K | Buy |
10,835
+7,023
| +184% | +$499K | ﹤0.01% | 2462 |
|
|
2022
Q4 | $255K | Sell |
3,812
-23,237
| -86% | -$1.51M | ﹤0.01% | 2912 |
|
|
2022
Q3 | $1.45M | Buy |
27,049
+20,187
| +294% | +$1.19M | ﹤0.01% | 2207 |
|
|
2022
Q2 | $382K | Sell |
6,862
-1,222
| -15% | -$69.3K | ﹤0.01% | 2797 |
|
|
2022
Q1 | $567K | Sell |
8,084
-8,278
| -51% | -$601K | ﹤0.01% | 2683 |
|
|
2021
Q4 | $1.58M | Sell |
16,362
-11,444
| -41% | -$1.06M | ﹤0.01% | 2238 |
|
|
2021
Q3 | $2.42M | Buy |
27,806
+22,686
| +443% | +$1.75M | ﹤0.01% | 1750 |
|
|
2021
Q2 | $419K | Sell |
5,120
-870
| -15% | -$72.4K | ﹤0.01% | 2613 |
|
|
2021
Q1 | $570K | Buy |
5,990
+2,511
| +72% | +$237K | ﹤0.01% | 2502 |
|
|
2020
Q4 | $216K | Buy |
3,479
+23
| +0.7% | +$1.31K | ﹤0.01% | 2850 |
|
|
2020
Q3 | $206K | Sell |
3,456
-1,210
| -26% | -$82.6K | ﹤0.01% | 2749 |
|
|
2020
Q2 | $326K | Sell |
4,666
-19,103
| -80% | -$1.21M | ﹤0.01% | 2278 |
|
|
2020
Q1 | $1.08M | Buy |
23,769
+18,450
| +347% | +$1.05M | ﹤0.01% | 1865 |
|
|
2019
Q4 | $346K | Sell |
5,319
-360
| -6% | -$24.1K | ﹤0.01% | 2691 |
|
|
2019
Q3 | $353K | Buy |
5,679
+2,151
| +61% | +$135K | ﹤0.01% | 2395 |
|
|
2019
Q2 | $251K | Sell |
3,528
-3,524
| -50% | -$260K | ﹤0.01% | 2466 |
|
|
2019
Q1 | $553K | Buy |
7,052
+4,994
| +243% | +$378K | ﹤0.01% | 2032 |
|
|
2018
Q4 | $174K | Sell |
2,058
-3,795
| -65% | -$405K | ﹤0.01% | 2131 |
|
|
2018
Q3 | $1M | Buy |
5,853
+2,214
| +61% | +$334K | ﹤0.01% | 1751 |
|
|
2018
Q2 | $470K | Sell |
3,639
-7,135
| -66% | -$796K | ﹤0.01% | 2042 |
|
|
2018
Q1 | $1.11M | Sell |
10,774
-3,047
| -22% | -$301K | ﹤0.01% | 1662 |
|
|
2017
Q4 | $1.18M | Sell |
13,821
-3,562
| -20% | -$309K | ﹤0.01% | 1845 |
|
|
2017
Q3 | $1.48M | Buy |
17,383
+7,504
| +76% | +$594K | ﹤0.01% | 1310 |
|
|
2017
Q2 | $748K | Sell |
9,879
-834
| -8% | -$58.3K | ﹤0.01% | 1687 |
|
|
2017
Q1 | $707K | Buy |
10,713
+1,342
| +14% | +$88.3K | ﹤0.01% | 1542 |
|
|
2016
Q4 | $594K | Buy |
9,371
+4,533
| +94% | +$286K | ﹤0.01% | 1600 |
|
|
2016
Q3 | $308K | Sell |
4,838
-4,652
| -49% | -$342K | ﹤0.01% | 1497 |
|
|
2016
Q2 | $706K | Buy |
9,490
+5,450
| +135% | +$404K | ﹤0.01% | 1333 |
|
|
2016
Q1 | $270K | Buy |
4,040
+191
| +5% | +$11.6K | ﹤0.01% | 1419 |
|
|
2015
Q4 | $260K | Sell |
3,849
-1,838
| -32% | -$113K | ﹤0.01% | 1335 |
|
|
2015
Q3 | $304K | Buy |
5,687
+3,347
| +143% | +$203K | ﹤0.01% | 1679 |
|
|
2015
Q2 | $147K | Buy |
2,340
+1,593
| +213% | +$86.9K | ﹤0.01% | 1882 |
|
|
2015
Q1 | $35.9K | Buy |
+747
| New | +$28.6K | ﹤0.01% | 2086 |
|
|
2014
Q4 | – | Sell |
-8,877
| Closed | -$260K | – | 2640 |
|
|
2014
Q3 | $260K | Buy |
8,877
+8,839
| +23,261% | +$293K | ﹤0.01% | 1768 |
|
|
2014
Q2 | $1.5K | Buy |
+38
| New | +$1.54K | ﹤0.01% | 3262 |
|
|
2014
Q1 | – | Sell |
-369
| Closed | -$12.1K | – | 3618 |
|
|
2013
Q4 | $12.1K | Sell |
369
-7,305
| -95% | -$238K | ﹤0.01% | 2521 |
|
|
2013
Q3 | $207K | Sell |
7,674
-2,225
| -22% | -$62.6K | ﹤0.01% | 2217 |
|
|
2013
Q2 | $231K | Buy |
+9,899
| New | +$178K | ﹤0.01% | 2216 |
|
Other funds holding LGND
JT
CAM
BNP Paribas Financial Markets's LGND Position: Q2 2026 in Review
BNP Paribas Financial Markets increased its Ligand Pharmaceuticals (LGND) stake by 169% in Q2 2026, buying an estimated $13.9M and bringing the position to 94,072 shares worth $29.7M. The position accounts for 0.01% of the portfolio, ranked #1032.
BNP Paribas Financial Markets first reported a position in LGND in Q2 2013 and has held it in 51 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- BNP Paribas Financial Markets held 94,072 shares of Ligand Pharmaceuticals worth $29.7M as of Q2 2026.
- BNP Paribas Financial Markets bought 59,157 Ligand Pharmaceuticals shares in Q2 2026, an estimated $13.9M.
- Ligand Pharmaceuticals made up 0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1032 holding.
- BNP Paribas Financial Markets first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
- 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.